Expression of CD47 in the pancreatic β‐cells of people with recent‐onset type 1 diabetes varies according to disease endotype

CD47 expression and CD163+ macrophages correlated with prognosis of pancreatic neuroendocrine tumor

(2021) Rami Imam et al.   BMC CANCER

Immunotherapy: Building a bridge to a cure for type 1 diabetes

(2021) Jeffrey A. Bluestone et al.   SCIENCE

Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosis

(2020) Pia Leete et al.   DIABETOLOGIA

CD47 decline in pancreatic islet cells promotes macrophage-mediated phagocytosis in type I diabetes

(2020) Jing Zhang et al.   World Journal of Diabetes

The promise of macrophage directed checkpoint inhibitors in myeloid malignancies

(2020) David M. Swoboda et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?)

(2020) Bart O. Roep et al.   Nature Reviews Endocrinology

What the HLA-I!—Classical and Non-classical HLA Class I and Their Potential Roles in Type 1 Diabetes

(2019) Rebecca C. Wyatt et al.   Current Diabetes Reports

Type 1 diabetes

(2018) Linda A DiMeglio et al.   LANCET

PDL1 is expressed in the islets of people with type 1 diabetes and is up-regulated by interferons-α and-γ via IRF1 induction

(2018) Maikel L. Colli et al.   EBioMedicine

The transcription factor STAT6 plays a critical role in promoting beta cell viability and is depleted in islets of individuals with type 1 diabetes

(2018) Kaiyven A. Leslie et al.   DIABETOLOGIA

SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels

(2018) Takayoshi Suga et al.   Molecular Metabolism

The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer

(2017) Hanke L. Matlung et al.   IMMUNOLOGICAL REVIEWS

Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies

(2015) J. Naidoo et al.   ANNALS OF ONCOLOGY

The CD47-SIRP  signalling system: its physiological roles and therapeutic application

(2014) Y. Murata et al.   JOURNAL OF BIOCHEMISTRY

Polymorphism in the Innate Immune Receptor SIRPα Controls CD47 Binding and Autoimmunity in the Nonobese Diabetic Mouse

(2014) Andrea Sut Ling Wong et al.   JOURNAL OF IMMUNOLOGY

The Interaction Between Signal Regulatory Protein Alpha (SIRPα) and CD47: Structure, Function, and Therapeutic Target

(2013) A. Neil Barclay et al.   Annual Review of Immunology

The diagnosis of insulitis in human type 1 diabetes

(2013) M. L. Campbell-Thompson et al.   DIABETOLOGIA

Immune therapy in type 1 diabetes mellitus

(2013) Åke Lernmark et al.   Nature Reviews Endocrinology

Differential effects of interleukin-13 and interleukin-6 on Jak/STAT signaling and cell viability in pancreatic β-cells

(2013) Mark A. Russell et al.   Islets

A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion

(2011) Philippe Ravassard et al.   JOURNAL OF CLINICAL INVESTIGATION

Implication of the CD47 pathway in autoimmune diabetes

(2010) Véronique Dugas et al.   JOURNAL OF AUTOIMMUNITY